Getagraph.com logo
S&P 500
(0.32%) 5 116.31 points
Dow Jones
(0.31%) 38 357 points
Nasdaq
(0.37%) 15 987 points
Oil
(-0.97%) $83.04
Gas
(5.36%) $2.03
Gold
(0.33%) $2 354.90
Silver
(0.56%) $27.69
Platinum
(4.26%) $961.40
USD/EUR
(-0.27%) $0.932
USD/NOK
(-0.45%) $10.98
USD/GBP
(-0.59%) $0.796
USD/RUB
(1.63%) $93.37

リアルタイムの更新： Cassava Sciences Inc [SAVA]

取引所: NASDAQ セクター: Healthcare 産業: Biotechnology
Upcoming Earnings Alert

Quarter results today
(tns 2024-04-29)

Expected move: +/- 8.13%

BUY
75.00%
return 5.74%
SELL
40.00%
return 3.32%
最終更新日時30 4月 2024 @ 01:51
25% discount on Stockinvest.us - Use code: Podcast

0.00% $ 22.34

買う 107767 min ago

@ $24.09

発行日: 15 2月 2024 @ 05:43

リターン: -7.26%

前回のシグナル: 2月 14 - 05:46

前回のシグナル: 売る

リターン: 0.75 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:51):
Profile picture for Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease...

Stats
本日の出来高 487 374
平均出来高 742 488
時価総額 965.65M
EPS $0 ( 2024-02-27 )
次の収益日 ( $-0.510 ) 2024-05-06
Last Dividend $5.25 ( 2012-12-13 )
Next Dividend $0 ( N/A )
P/E -9.63
ATR14 $0.0210 (0.09%)
Insider Trading
Date Person Action Amount type
2024-04-23 Barry Richard Buy 176 085 Common Stock
2024-01-03 Barry Richard Buy 117 390 Common Stock Warrant
2024-04-23 Barry Richard Sell 117 390 Common Stock Warrant
2024-04-18 Kupiec James William Buy 1 500 Common Stock
2024-01-03 Kupiec James William Buy 1 000 Common Stock Warrant
INSIDER POWER
68.79
Last 91 transactions
Buy: 2 039 016 | Sell: 658 296

ボリューム 相関

長: -0.05 (neutral)
短: 0.61 (weak)
Signal:(52.456) Neutral

Cassava Sciences Inc 相関

10 最も正の相関
CBIO0.848
GOOD0.844
ALXO0.828
ANGN0.828
CTBI0.825
MIRO0.819
RPRX0.813
CMPX0.813
DCRC0.808
BLUE0.806
10 最も負の相関
RNA-0.87
VKTX-0.844
BWMX-0.833
MTRY-0.832
DKDCA-0.826
CFFE-0.823
ROCL-0.821
LRMR-0.821
AMPH-0.814
EDTX-0.811

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Cassava Sciences Inc 相関 - 通貨/商品

The country flag -0.24
( neutral )
The country flag -0.36
( neutral )
The country flag 0.00
( neutral )
The country flag -0.17
( neutral )
The country flag 0.10
( neutral )
The country flag -0.24
( neutral )

Cassava Sciences Inc 財務諸表

Annual 2023
収益: $0
総利益: $-1.53M (0.00 %)
EPS: $-2.32
FY 2023
収益: $0
総利益: $-1.53M (0.00 %)
EPS: $-2.32
FY 2022
収益: $-1 800.00
総利益: $-1.30M (72 377.78 %)
EPS: $-1.800
FY 2021
収益: $0.00
総利益: $0.00 (0.00 %)
EPS: $-0.820

Financial Reports:

No articles found.

Cassava Sciences Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A)

Cassava Sciences Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $14.00 2010-12-13
Last Dividend $5.25 2012-12-13
Next Dividend $0 N/A
Payout Date 2012-12-24
Next Payout Date N/A
# dividends 2 --
Total Paid Out $19.25 --
Avg. Dividend % Per Year 0.00% --
Score 0.22 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
 (2024-10-04)
$0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
0.22
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2010 $14.00 37.20%
2011 $0 0.00%
2012 $5.25 19.20%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-40.281.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.6241.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.5601.500-7.33-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM9.130.80010.008.00[1 - 3]
quickRatioTTM8.600.80010.008.00[0.8 - 2.5]
cashRatioTTM8.531.50010.0010.00[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM-1.9442.00-0.648-1.296[0 - 30]
freeCashFlowPerShareTTM-1.9542.00-0.977-1.954[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.3481.0007.537.53[0.2 - 0.8]
operatingProfitMarginTTM-45.291.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM0.01550.800-3.23-2.58[0.5 - 2]
Total Score-1.853

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-9.961.000-1.1080[1 - 100]
returnOnEquityTTM-0.5602.50-4.71-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-1.9542.00-0.651-1.954[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-1.9442.00-0.648-1.296[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM1.7941.5001.3760[0.5 - 2]
operatingCashFlowSalesRatioTTM-34.931.000-10.000[0.1 - 0.5]
Total Score-2.16

Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。